Rahika 200mg Tablet: Effective Relief for Your Needs

Rahika 200mg Tablet

Uses:

• Treatment of adults with non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change in the MET gene.

Active ingredient:

• Capmatinib

Therapeutic effects:

• Rahika 200mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET).
• It works by blocking the action of this abnormal protein that signals cancer cells to multiply.
• This helps slow or stop the spread of cancer cells.

Important safety information:

• Do not take if allergic to Rahika 200mg tablet or any ingredients.
• Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems.
• Avoid getting pregnant and breastfeeding during treatment.
• Store at 20°C to 25°C.
• Protect the medicine from light and excessive moisture.
• Keep the medicine out of reach of children and pets.

Dosage and administration:

• It is an orally available prescription drug.
• Your doctor will decide the dose and duration of Rahika 200mg tablet based on the disease condition and other factors.
• Always take this medicine as prescribed by your doctor.
• Take the tablet with or without food.
• Do not break, chew, crush, or break the tablet.
• Swallow the whole tablet with water.

Side effects:

• Common: swelling in the face and body, decrease in appetite, nausea, cough, fatigue.
• Serious: vomiting, liver injury, muscle pain, shortness of breath, lung infection, respiratory disease.

FAQs:

• Q1: Inform your physician about all your medical and medication history, including over-the-counter medicines and nutritional or vitamin supplements you are taking.
• Q2: The duration of your treatment depends on your disease condition and severity. Your doctor will decide your dose and duration of your treatment.
• Q3: Yes, Rahika 200mg tablet is safe when prescribed to patients with kidney diseases. No dose adjustments are necessary.
• Q4: Yes, Rahika 200mg tablet is a targeted therapy. They work by targeting a mutation in MET gene.
• Q5: If you overdose on the medicine unintentionally or accidentally, seek medical advice immediately. Do not overdose on the medicine.

Fact box:

• Molecule name: Capmatinib
• Therapeutic class: Anti-cancer
• Pharmacological class: Protein Kinase Inhibitors
• Indications: Non-small cell lung cancer (NSCLC)

Tags: Rahika, Tablet, Medicine, 200mg, Health, Pharmacology